Silver Spring, MD, United States of America

Mena Schiano Lo Moriello

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mena Schiano Lo Moriello: Innovator in Human Tissue Derived Compositions

Introduction

Mena Schiano Lo Moriello is a notable inventor based in Silver Spring, MD (US). He has made significant contributions to the field of biomedical innovations, particularly in the area of human tissue derived compositions. With a total of 2 patents, his work focuses on advancing medical treatments and improving patient outcomes.

Latest Patents

Mena's latest patents include innovative compositions that comprise a non-homogenized chorionic matrix, a homogenized amniotic matrix, and a homogenized umbilical cord (UC) matrix. These compositions are designed to include viable cells within the non-homogenized chorionic matrix. The patents also disclose methods for creating these compositions, which involve preparing the various matrices and combining them effectively. Furthermore, the patents outline methods for treating tissue injuries or chronic pain by administering these compositions to affected areas of a subject.

Career Highlights

Mena Schiano Lo Moriello is currently associated with Osiris Therapeutics, Inc., a company known for its focus on regenerative medicine. His work at Osiris Therapeutics has allowed him to explore and develop groundbreaking solutions in the field of tissue engineering and regenerative therapies.

Collaborations

Mena collaborates with esteemed colleagues such as Steven Michael Sinclair and Alla Danilkovitch, who contribute to the innovative environment at Osiris Therapeutics. Their combined expertise fosters a collaborative approach to research and development in regenerative medicine.

Conclusion

Mena Schiano Lo Moriello's contributions to the field of human tissue derived compositions highlight his role as an influential inventor. His innovative patents and work at Osiris Therapeutics demonstrate a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…